Engineered self-regulating macrophages for targeted anti-inflammatory drug delivery

Molly Klimak,Amanda Cimino,Kristin L. Lenz,Luke E. Springer,Kelsey H. Collins,Natalia S. Harasymowicz,Nathan Xu,Christine T.N. Pham,Farshid Guilak
DOI: https://doi.org/10.1186/s13075-024-03425-3
2024-11-07
Arthritis Research & Therapy
Abstract:Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by increased levels of inflammation that primarily manifests in the joints. Macrophages act as key drivers for the progression of RA, contributing to the perpetuation of chronic inflammation and dysregulation of pro-inflammatory cytokines such as interleukin 1 (IL-1). The goal of this study was to develop a macrophage-based cell therapy for biologic drug delivery in an autoregulated manner.
rheumatology
What problem does this paper attempt to address?